« Back to Research Deepdives

Is Vitamin E E-ffective for Treating Fatty Liver Disease?

This content is restricted to members.

To view our premium content, sign up for a membership:


Register New Account

Choose your membership level

Choose Your Payment Method

‹ Back to Research Deepdives


  1. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology. 2006 Feb;43(S1):S99–112.
  2. Perumpail B, Li A, John N, Sallam S, Shah N, Kwong W, et al. The Role of Vitamin E in the Treatment of NAFLD. Diseases. 2018 Sep 24;6(4):86.
  3. Pacana T, Sanyal AJ. Vitamin E and nonalcoholic fatty liver disease. Current Opinion in Clinical Nutrition and Metabolic Care. 2012 Nov;15(6):641–8.
  4. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012 Jun;142(7):1592–609.
  5. Morrissey PA, Sheehy PJA. Optimal nutrition: Vitamin E. Proceedings of the Nutrition Society. 1999 May;58(2):459-68.
  6. Ahsan H, Ahad A, Iqbal J, Siddiqui WA. Pharmacological potential of tocotrienols: a review. Nutrition & Metabolism. 2014 Dec 12;11(1):52.
  7. Vasanthi HR, Parameswari RP, Das DK. Multifaceted role of tocotrienols in cardioprotection supports their structure: function relation. Genes & Nutrition. 2012 Jan 21;7(1):19–28.
  8. Lavine JE, Nonalcoholic Steatohepatitis Clinical Research Network. Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents. JAMA. 2011 Apr 27;305(16):1659.
  9. Sanyal AJ, Chalasani N, Kowdley K v., McCullough A, Diehl AM, Bass NM, et al. Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis. New England Journal of Medicine. 2010 May 6;362(18):1675–85.